COMMUNIQUÉS West-GlobeNewswire

Allergy Therapeutics: Trading Update
18/07/2017
Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Trading Update 15% constant currency revenue growth Double-digit compound annual revenue growth over the past 18 years 18 July 2017 Allergy Therapeutics [...]
Midatech Pharma Plc: Trading Update and Notice of Results
18/07/2017
18 July 2017 Midatech Pharma PLC ("Midatech", "Company" or "Group") Trading Update and Notice of Results Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing [...]
uniQure Expands Intellectual Property Portfolio with Newly Issued Patent Providing Broad Protection of Insect Cell-Based AAV Manufacturing
18/07/2017
Patent Covers Overlapping Rep78/52 Nucleotide Sequences for Robust, Large-Scale Production of AAV Constructs LEXINGTON, Mass. and AMSTERDAM, the Netherlands, July 18, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE [...]
Enzymatica recruits Chief Commercial Officer
18/07/2017
Press release Lund, 18 July 2017 Enzymatica recruits Chief Commercial Officer Enzymatica has recruited Claus Egstrand as its Chief Commercial Officer. Claus Egstrand's primary responsibility will be to develop [...]
CellaVision AB: Strong second quarter with growth and increased profitability
18/07/2017
Interim report January-June 2017 April 1-June 30, 2017 · Net sales increased by 20 % to SEK 78.7 million (65.7). · Organic growth for the quarter was 16% (27). · Operating profit increased by 29% to SEK 24.6 million (19 [...]
Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products
18/07/2017
Net sales in line with prior year (0% cc[1], -2% USD), as growth drivers offset Gleevec/Glivec Gx impact: Cosentyx (USD 490 million, +90% cc) continues strong growth in all three indications Entresto (USD 110 million) [...]
Les résultats du T2 confirment les prévisions de l'exercice 2017. Les très bons résultats du pipeline étayent le potentiel de plusieurs produits hautement novateurs
18/07/2017
Chiffre d'affaires net comparable à celui du T2 de l'exercice précédent (0% tcc[1], -2% en USD), car les moteurs de croissance ont compensé l'impact des génériques de Gleevec/Glivec : Cosentyx (USD 490 millions, +90% [...]
EDAP Announces Withdrawal of 510(k) Application for Focal One® to be Followed by New Submission to Conform to FDA Review Rules
17/07/2017
New 510(k) With New Clinical Data to be Submitted for Focal One® Initial 510(k) to be submitted for Ablatherm Fusion® LYON, France, July 17, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in [...]
Ossur Hf : Transactions in relation to share buyback program
17/07/2017
A nnouncement from Össur hf. No. 50/2017 Reykjavík, 17 July 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]
Sanofi : Disclosure of trading in own shares
17/07/2017
Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Sanofi : Déclaration des transactions sur actions propres
17/07/2017
Reporting FR This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Diaxonhit : mise en oeuvre du regroupement d'actions par 20 entre le 1er août et le 1er septembre 2017
17/07/2017
MISE EN OEUVRE DU REGROUPEMENT D'ACTIONS DIAXONHIT Regroupement d'actions par voie d'échange à raison de 1 action nouvelle regroupée contre 20 actions anciennes ; Début des opérations de regroupement : 1 er août 2017 ; [...]
Virbac : la croissance du chiffre d'affaires au deuxième trimestre rattrape en grande partie le recul du premier trimestre
17/07/2017
Virbac : la croissance du chiffre d'affaires au deuxième trimestre rattrape en grande partie le recul du premier trimestre Communiqué diffusé le 17 juillet 2017 Le chiffre d'affaires du Groupe au deuxième trimestre s' [...]
Virbac: second quarter sales growth largely offsets the decline in the first quarter
17/07/2017
Virbac: second quarter sales growth largely offsets the decline in the first quarter Public release - July 17, 2017 Virbac consolidated revenue in the second quarter amounted to €234.8 million, up sharply by +7.5% [...]
Solon Eiendom ASA : Primary insider notification
17/07/2017
(Oslo, Norway, 17 July 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Dukat AS) has today bought 25,000 shares in Solon Eiendom ASA at a price of NOK 19. Following this [...]
Solon Eiendom ASA : Primary insider notification
17/07/2017
(Oslo, Norway, 17 July 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 80,986 shares in Solon Eiendom ASA at a price of NOK 18,9888. Following [...]
Targovax ASA: Final result of the subsequent offering
17/07/2017
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]
Five-Year Data Demonstrate InterStim(TM) Therapy Offers Sustained Long-Term Efficacy and Quality of Life Improvements for Overactive Bladder Patients
17/07/2017
The InterStim System is the Only Proven, Long-Term Sacral Neuromodulation Solution for Overactive Active Bladder DUBLIN - July 17, 2017 - Medtronic plc (NYSE: MDT) today announced that the InterStim(TM) system, which [...]
RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D
17/07/2017
Top-line results are expected in September 2017 The randomized, double-blind, placebo-controlled Phase II study is evaluating the safety and efficacy of BEKINDA ® (RHB-102) 12 mg in 127 U.S. patients with diarrhea- [...]

Pages